Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Torrent Pharma has collaborated with Cipla, Dr. Reddy’s, Emcure and Sun Pharma for clinical trials of investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in an outpatient setting in India.
According to SEC of CDSCO, Dr. Reddy’s will conduct the clinical trial using its product, and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr. Reddy’s in its clinical trial.
Europe Union’s new move may hit India, South Africa’s patent waiver plan
European Union has drawn up a counter proposal which could ``undermine’’ India and South Africa’s proposed submission at the World Trade Organization seeking a waiver on intellectual property (IP) on Covid-19 drugs and vaccines.
If adopted at the WTO, the waiver would provide countries with critical policy space to address IP barriers to increase collaboration in research and development, manufacturing, scale-up, and hence boost supply of Covid-19 medicines and vaccines.
The EU proposal calls governments to ``facilitate the use of compulsory licensing within the WTO’s existing agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).